Seoul, South Korea

Ye Sun Han

This inventor holds 5 USPTO granted patents. Top assignee: Korea Institute of Science and Technology. Active years: 2000-2006.


% Patents Active = 20.0

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ye Sun Han: Innovator in Hepatitis B Research

Introduction

Ye Sun Han is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biomedical research, particularly in the study of Hepatitis B virus. With a total of 5 patents, his work has garnered attention for its innovative approaches to complex biological challenges.

Latest Patents

One of Ye Sun Han's latest patents involves a complex of Hepatitis B virus polymerase with p11. This invention discloses a method for controlling the movement of the HBVPol/p11 complex into the nucleus of HepG2 cells by adjusting intracellular calcium ion concentration. This method could have important implications for the treatment of Hepatitis B. Another notable patent describes a compound represented by a general formula (Ia) or (Ib) and a stereo-selective preparation method using a carbonyl reductase. This compound can be prepared by the reduction of substituted β-keto esters and serves as an intermediate in the preparation of β-lactam group antibiotics.

Career Highlights

Ye Sun Han is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work is characterized by a strong focus on the molecular mechanisms of viral infections and the development of therapeutic strategies.

Collaborations

He has collaborated with notable colleagues, including Juhyun Choi and Hyewhon Rhim, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Ye Sun Han's contributions to the field of Hepatitis B research exemplify the impact of innovative thinking in addressing complex health issues. His patents reflect a commitment to advancing medical science and improving treatment options for viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…